Independence of HIF1a and androgen signaling pathways in prostate cancer.
Maxine G B TranBecky A S BibbyLingjian YangFranklin LoAnne Y WarrenDeepa ShuklaMichelle OsborneJames HadfieldThomas CarrollRory StarkHelen ScottAntonio Ramos-MontoyaCharlie MassiePatrick MaxwellCatharine M L WestIan Geoffrey MillsDavid E NealPublished in: BMC cancer (2020)
The oncogenic AR, hypoxia and HIF1a pathways support prostate cancer development through independent signaling pathways and transcriptomic profiles. AR and hypoxia/HIF1a signaling pathways independently promote prostate cancer progression and therapeutic targeting of both pathways simultaneously is warranted.